The financial well-being of Fairview Health Services is a central element of merger talks with Sanford Health, even as executives downplay it as a motivation and industry trends make the urgency difficult to assess.
Minneapolis-based Fairview reported an operating loss of $248.5 million through the first nine months of this year. The hospital operator has plenty of company, however, as many health systems are struggling financially due in part to rising labor costs.
Fairview's arrangement with the University of Minnesota is unique and adds to the complexity, because the U plays a significant role both in the health system's financial results and its quality of care.
Sioux Falls-based Sanford Health now says that if the merger goes through as hoped next year, it is prepared — absent a new agreement — to keep funding academic medicine at the University of Minnesota until the current long-term deal between the U and Fairview expires in 2026.
What happens after that is one of the big unanswered questions with the proposed health system mega-merger.
Nancy Kane, a hospital finance researcher at the Harvard T. H. Chan School of Public Health, said that despite Fairview's recent losses, bond ratings from fall 2021 suggest financial health.
Like many institutions and investors, Fairview has lost money on its investment portfolio with this year's market downturn, Kane said, yet it still had just over $2 billion in cash and investments at the end of September.
"They need to do something — you don't want to keep losing money every year," Kane said. "But it's not urgent that they be acquired by a larger organization that may or may not make them more efficient."